MannKind Corp
MNKD
#6019
Rank
โ‚น106.85 B
Marketcap
โ‚น332.32
Share price
0.00%
Change (1 day)
-32.44%
Change (1 year)

EPS for MannKind Corp (MNKD)

EPS in 2026 (TTM): -โ‚น12.19

According to MannKind Corp's latest financial reports the company's current EPS (TTM) is -โ‚น12.34. In 2025 the company made an earnings per share (EPS) of โ‚น1.90 a decrease over its 2024 EPS that were of โ‚น9.49.

EPS history for MannKind Corp from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น12.19-742.05%
2025โ‚น1.90-80%
2024โ‚น9.49
2022-โ‚น32.286.25%
2021-โ‚น30.3828%
2020-โ‚น23.74-7.41%
2019-โ‚น25.64
2017-โ‚น105.39-188.1%
2016โ‚น119.64-128.31%
2015-โ‚น422.5374.51%
2014-โ‚น242.12-20.31%
2013-โ‚น303.84-32.63%
2012-โ‚น451.01-28.03%
2011-โ‚น626.67

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น72.16-684.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
โ‚น387.17-3,236.63%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Eli Lilly
LLY
โ‚น2,837-23,087.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น120.16-1,073.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
โ‚น334.22-2,807.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-โ‚น636.16 5,053.85%๐Ÿ‡บ๐Ÿ‡ธ USA